Medical Data Firm Tempus AI Raises $410.7 Million in IPO
(Bloomberg) -- Tempus AI Inc., a technology platform company using artificial intelligence to process medical data, priced its initial public offering at the top of a marketed range to raise $410.7 million.
Most Read from Bloomberg
Wells Fargo Fires Over a Dozen for ‘Simulation of Keyboard Activity’
Tesla Investors Back Musk’s $56 Billion Pay Deal, Texas Move
Apple to ‘Pay’ OpenAI for ChatGPT Through Distribution, Not Cash
Hunter Biden Was Convicted. His Dad’s Reaction Was Remarkable.
Tech Powers Stocks as Adobe Surges in Late Trading: Markets Wrap
Joining a rush of companies going public while touting their AI credentials, Tempus sold 11.1 million shares for $37 each after offering them for $35 to $37, according to a statement Thursday confirming an earlier report by Bloomberg News.
At the IPO price, the company has a market value of $6.1 billion based on the outstanding shares listed in its filings with the US Securities and Exchange Commission.
Chicago-based Tempus AI, founded in 2015, describes its business as creating “intelligent diagnostics” for precision medicine.
The company’s platform connects laboratory results to a patient’s own clinical data, and has been used by more than 7,000 physicians across hundreds of provider networks, according to its filings. It has a team of about 2,300 employees, with about 250 of them holding medical degrees or doctorates.
Tempus AI had a net loss of $214 million on revenue of $532 million in 2023, compared with a net loss of $290 million on revenue of $321 million a year earlier, according to the filing.
The company’s largest investors include Eric Lefkofsky, the founder and chief executive officer, as well as a firm controlled by Kimberly Keywell and entities affiliated with Baillie Gifford & Co. The company has a dual-class share structure that will give Lefkofsky 65% of the shareholder voting power after the IPO.
The offering is being led by Morgan Stanley, JPMorgan Chase & Co. and Allen & Co. The company’s shares are expected to begin trading Friday on the Nasdaq Global Select Market under the symbol TEM.
(Updates with statement in second paragraph.)
Most Read from Bloomberg Businessweek
Israeli Scientists Are Shunned by Universities Over the Gaza War
Grieving Families Blame Panera’s Charged Lemonade for Leaving a Deadly Legacy
The World’s Most Online Male Gymnast Prepares for the Paris Olympics
China’s Economic Powerhouse Is Feeling the Brunt of Its Slowdown
©2024 Bloomberg L.P.